Investing in pharmaceutical companies should consider their pipeline strength over current profits, as temporary sales of blockbuster drugs can impact earnings. Pfizer and AbbVie exemplify this, with Pfizer’s Covid vaccine sales boosting profits temporarily, while AbbVie’s Humira faced generic competition but had new drugs in the pipeline. Companies like Novo Nordisk and Eli Lilly are focusing on weight-loss drugs with additional benefits, while AstraZeneca and Merck are prominent in the cancer drug market. Assessing investment potential, Novo and AstraZeneca offer lower risk, Eli Lilly and AbbVie provide reasonable risk/reward profiles, and Merck poses higher risk due to dependency on Keytruda.
Full Article
Tommy Bahama maker Oxford depends on Florida for sales. It just cut its outlook following hurricanes Milton and Helene.
Shares of Oxford Industries dropped in after-hours trading following the company's decision to lower its full-year forecast due to the impact of hurricanes Milton and Helene on its primary market, the Southeast U.S. The maker of popular clothing brands like Tommy Bahama and Lilly Pulitzer cited the severe weather conditions in the region as a key factor affecting its financial outlook. Full Article
Read more